A Long Term, Post-marketing Study of Immune Response in Patients Receiving Palynziq Treatment for PKU (PALisade)

NCT06305234 · clinicaltrials.gov ↗

RECRUITING

Status

200

Enrollment

INDUSTRY

Sponsor class

Conditions

Phenylketonuria (PKU)

Interventions

DRUG: Pegvaliase

Sponsor

BioMarin Pharmaceutical